Summary
- Current Price
- As of today, CGON price is $54.42, down -2.00% on
- Current Price All-Time High
- CGON price is currently -27.92% below its historical high of $75.50 set on
- Market Cap
- CGON current market cap is $5B, up +135.05% over the past 365 days
- PE Ratio
- CGON PE ratio is unknown
- Revenue
- CGON current annual revenue is $4.04M, up +254.70% year-over-year
- Next Earnings
- The next earnings release for CGON is on
Profile
| Metric | Value |
|---|---|
| Full Name | CG Oncology, Inc. |
| Ticker | NASDAQ: CGON |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cgoncology.com |
| Employees | 113 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $54.42 | |
| Price, 1D Change | -2.00% | |
| $5B | ||
| - | ||
| - | ||
| 1.20 | ||
| $4M | ||
| Revenue, 1Y Change | +254.70% | |
| -$2.08 | ||
| EPS, 1Y Change | -80.16% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.08 | ||
| EPS Estimate | N/A | -$2.66 |
| EPS Est. Change | N/A | -27.49% |
| $4.04M | ||
| Revenue Estimate | N/A | $11.73M |
| Revenue Est. Change | N/A | +190.44% |
| Current Price | $54.42 | |
| Price Target | - | $88.50 |
| Price Tgt. Change | - | +62.62% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.35 | -$1.16 | +14.37% | |
| -$2.08 | -$2.08 | -0.26% | |
| -$2.66 | N/A | -27.49% | |
| -$2.78 | N/A | -33.45% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.39M | $1.14M | -18.22% | |
| $2.80M | $4.04M | +44.13% | |
| $11.73M | N/A | +190.44% | |
| $90.41M | N/A | +2,137.77% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $54.42 | |
| $50.15 | ||
| $66.42 | ||
| $52.74 | ||
| $64.00 | ||
| -$2.73 | ||
| 1.20 | ||
| $3.16 | ||
| 28.49 | ||
| 45.72% | ||
| 56.85% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $4.04M | ||
| -$2.08 | ||
| $0.00 | ||
| -50.79% | ||
| -$190.77M | ||
| -4,722.13% | ||
| -$161.00M | ||
| -3,985.02% | ||
| -$189.33M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 24.63 | ||
| 24.58 | ||
| - | ||
| 3 | ||
| 74.30 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 946.55 | ||
| 4.40 | ||
| -17.54 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $752.60M | ||
| $742.16M | ||
| $791.59M | ||
| $759.48M | ||
| $38.99M | ||
| $30.84M | ||
| $7.02M | ||
| $915.00K | ||
| $5.71M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $165.04M | ||
| $188.72M | ||
| $6.09M | ||
| $73.53M | ||
| $1.45M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$132.35M | ||
| -$245.82M | ||
| $153.59M | ||
| $134.00K | ||
| -$132.48M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wolfe Research | ||
| HC Wainwright & Co. | → | |
| Truist Securities | → | |
| Wedbush | → | |
| Truist Securities | → | |
| RBC Capital | → | |
| JP Morgan | → | |
| RBC Capital | → | |
| JP Morgan | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with CGON
FAQ
What is the ticker symbol for CG Oncology, Inc.?
The ticker symbol for CG Oncology, Inc. is NASDAQ:CGON
Does CG Oncology, Inc. pay dividends?
No, CG Oncology, Inc. does not pay dividends
What sector is CG Oncology, Inc. in?
CG Oncology, Inc. is in the Healthcare sector
What industry is CG Oncology, Inc. in?
CG Oncology, Inc. is in the Biotechnology industry
What country is CG Oncology, Inc. based in?
CG Oncology, Inc. is headquartered in United States
When did CG Oncology, Inc. go public?
CG Oncology, Inc. initial public offering (IPO) was on January 25, 2024
Is CG Oncology, Inc. in the S&P 500?
No, CG Oncology, Inc. is not included in the S&P 500 index
Is CG Oncology, Inc. in the NASDAQ 100?
No, CG Oncology, Inc. is not included in the NASDAQ 100 index
Is CG Oncology, Inc. in the Dow Jones?
No, CG Oncology, Inc. is not included in the Dow Jones index
When was CG Oncology, Inc. last earnings report?
CG Oncology, Inc.'s most recent earnings report was on May 8, 2026
When does CG Oncology, Inc. report earnings?
The next expected earnings date for CG Oncology, Inc. is August 7, 2026
Data Sources & References
- CGON Official Website cgoncology.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1991792/000119312526079498/0001193125-26-079498-index.htm
- CGON Profile on Yahoo Finance finance.yahoo.com/quote/CGON
- CGON Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cgon